DGAP-Adhoc

H&R GmbH & Co. KGaA: Preliminary figures for Q3-2020 - Seite 2

Looking at the entire nine-month period 2020, EBITDA showed a significant decrease compared to the previous year. This was caused by the already weak earnings at mid-year. Coming from overall lower sales revenue (nine months 2020: EUR 649.9 million; nine months 2019: EUR 824.7 million), the company provisionally achieved an operating result (EBITDA) of EUR 30.7 million (nine months 2019: EUR 44.8 million). Higher depreciation weighed on EBIT, which amounted to EUR -6.8 million (nine months 2019: EUR 11.4 million). Earnings before taxes (EBT) showed a comparable trend at EUR -12.8 million (nine months 2019: EUR 5.6 million). The shareholders' net result closed at EUR -14.8 million (nine months 2019: EUR 4.1 million). H&R KGaA thus generated earnings per share of EUR -0.40. With EUR -0.03 in the third quarter of 2020 (nine months 2019: EUR 0.11; Q3-2019: EUR -0.16) this was recently almost balanced.

However, positive trends and a more dynamic development have been recorded since mid-2020. Overall, September 2020 turned out to be the most profitable month of the current financial year so far.

The ChemPharm Sales segment again made the main contribution to earnings. With EUR 6.5 million in the third quarter and EUR 17.8 million in the nine-month period, our international activities recorded rising, but overall lower operating results during the year (Q3-2019: EUR 7.3 million; nine months 2019: EUR 22.5 million). Sales revenues for the nine-month period remained significantly below the previous year at EUR 229.5 million (nine months 2019: EUR 285.4 million).

The ChemPharm Refining segment performed significantly better in the third quarter of 2020 with an EBITDA of EUR 8.7 million than in the same quarter of the previous year (Q3-2019: EUR 4.1 million). At EUR 15.7 million (nine months 2019: EUR 27.0 million), however, the noticeable recovery since June did not compensate for the burdens that the corona lockdown measures already had on the half-year result. Sales in the segment also remained lower and reached EUR 397.5 million for the nine-month period (nine months 2019: EUR 513.8 million).